Rubicon Research Ltd

Integrated Filing — Corporate Governance (NSE XBRL)

Company Home Dashboard NSE Viewer

Filing Summary

Company
Rubicon Research Limited
Symbol
RUBICON
Quarter Ended
31-Mar-2026
Submission
New

General Disclosures

Advertisements As Per Regulation471
Yes
Annual Return As Provided Under Section92Of The Companies Act2013
Yes
Approval For Material Related Party Transactions
Not Applicable
Approval Of The Board And Shareholders For Compensation Or Profit Sharing
Yes
Audio Or Video Recordings And Transcripts Of Post Earinings Or Quarterly Calls
Yes
Board Composition
Yes
Code Of Conduct
Yes
Compliance Certificate
Yes
Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation
Yes
Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46
Yes
Credit Rating Or Revision In Credit Rating Obtained
Yes
Date Of End Of Financial Year
31-Mar-2026
Date Of End Of Reporting Period
31-Mar-2026
Date Of Signing
28-Apr-2026
Date Of Start Of Financial Year
01-Apr-2025
Designation Of Person
Company Secretary and Compliance Officer
Designation Of Person Affirmations
Company Secretary and Compliance Officer
Designation Of Person For Annual Affirmations
Company Secretary and Compliance Officer
Designation Of Person For Quartely Affirmations
Company Secretary and Compliance Officer
Details Of Agreements Entered Into With The Media Companies And Or Their Associates
Not Applicable
Details Of Business
Yes
Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy
Yes
Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30
Yes
Disclosure Of Related Party Transactions On Consolidated Basis
Yes
Disclosure Web Link Of Annual Return As Provided Under Section92Of The Companies Act2013Is Placed
https://www.rubicon.co.in/pdf/Annual%20Return%20FY%202024.pdf
Disclosure Web Link Of Audio Or Video Recordings And Transcripts Of Post Earinings Or Quarterly Calls Is Placed
https://www.rubicon.co.in/recordings/10039745.mp3
Disclosure Web Link Of Company At Advertisements As Per Regulation471Is Placed
https://www.rubicon.co.in/pdf/corporate-announcement/Rubicon_Newspaper%20Advertisement_05.02.2026.pdf
Disclosure Web Link Of Company At Dividend Distribution Policy As Per Regulation43A1Is Placed
https://www.rubicon.co.in/pdf/Dividend%20distribution%20Policy.pdf
Disclosure Web Link Of Company At Materiality Policy As Per Sub Regulation4Regulation30Is Placed
https://www.rubicon.co.in/pdf/Policy%20for%20Determining%20Materiality%20of%20Events%20or%20Information%20for%20Disclosure.pdf
Disclosure Web Link Of Company At Separate Audited Financial Statements Of Each Subsidiary Of The Listed Entity Is Placed
https://www.rubicon.co.in/reports-filings
Disclosure Web Link Of Company At Which Credit Rating Or Revision In Credit Rating Obtained Is Placed
https://www.rubicon.co.in/pdf/Credit%20Raitng%20-%202025.pdf
Disclosure Web Link Of Company At Which Details Of Business Is Placed
https://www.rubicon.co.in/know-us
Disclosure Web Link Of Company At Which Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy Is Placed
https://www.rubicon.co.in/pdf/Whistle%20Blower%20and%20Vigil%20Mechanism%20Policy.pdf
Disclosure Web Link Of Company At Which Financial Results Is Placed
https://www.rubicon.co.in/reports-filings
Disclosure Web Link Of Company At Which Policy For Determining Material Subsidiaries Is Placed
https://www.rubicon.co.in/pdf/Policy-on-Material-Subsidiaries.pdf
Disclosure Web Link Of Company At Which Policy On Dealing With Related Party Transactions Is Placed
https://www.rubicon.co.in/pdf/Related-Party-Transactions-Policy.pdf
Disclosure Web Link Of Company At Which Shareholding Pattern Is Placed
https://www.rubicon.co.in/disclosures/SHP_Rubicon_31122025.pdf
Disclosure Web Link Of Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation Is Placed
https://www.rubicon.co.in/investors#
Disclosure Web Link Of Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46Is Placed
https://www.rubicon.co.in/investors#
Disclosure Web Link Of Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30Is Placed
https://www.rubicon.co.in/pdf/Contact%20details%20of%20Key%20Managerial%20Personnel%20for%20determining%20Materiality.pdf
Disclosure Web Link Of Disclosures Under Sub Regulation8Of Regulation30Is Placed
https://www.rubicon.co.in/investors#
Disclosure Web Link Of Employee Benefit Scheme Documents Framed In Terms Of SEBI Share Based Employee Benefits And Sweat Equity Regulations2021Is Placed
https://www.rubicon.co.in/pdf/Employee%20Benefit%20Scheme%20.pdf
Disclosure Web Link Of Memorandum Of Association And Articles Of Association Is Placed
https://www.rubicon.co.in/pdf/MOA%20%20AOA.pdf
Disclosure Web Link Of Schedule Of Analyst Or Institutional Investor Meet And Presentation Prepared By Listed Entity For Analyst Or Institutional Investor Meet Is Placed
www.rubicon.co.in/pdf/corporate-announcement/Announcement%20under%20Regulation%2030%20(LODR)%20Analyst%20%20Investor%20Meet%20-%20Intimation.pdf
Disclosures Under Sub Regulation8Of Regulation30
Yes
Dividend Distribution Policy As Per Regulation43A1
Yes
Employee Benefit Scheme Documents Framed In Terms Of SEBI Share Based Employee Benefits And Sweat Equity Regulations2021
Yes
Fees Or Compensation
Yes
Financial Results
Yes
Is SCORESID Available
Yes
ISIN
INE506V01022
Market Capitalisation As Per Immediate Previous Financial Year
Any other
Materiality Policy As Per Sub Regulation4Regulation30
Yes
Memorandum Of Association And Articles Of Association
Yes
Minimum Information
Yes
MSEI Symbol
NOTLISTED
Name Of Signatory
Ms. Deepashree Tanksale
Name Of Signatory Affirmations
Ms. Deepashree Tanksale
Name Of Signatory For Annual Affirmations
Ms. Deepashree Tanksale
Name Of Signatory For Quartely Affirmations
Ms. Deepashree Tanksale
Name Of The Company
RUBICON RESEARCH LIMITED
New Name And The Old Name Of The Listed Entity
Not Applicable
Other Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity
Yes
Place
Thane
Plans For Orderly Succession For Appointments
Yes
Policy For Determining Material Subsidiaries
Yes
Policy For Related Party Transaction
Yes
Policy On Dealing With Related Party Transactions
Yes
Reason For Part F Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Loans Or Guarantees Or Comfort Letters Or Securities Etc Is Not Applicable To The Entity
Nothing to Report.
Recommendation Of Board
Yes
Reporting Quarter
Yearly
Review Of Compliance Reports
Yes
Risk Assessment And Management
Yes
Schedule Of Analyst Or Institutional Investor Meet And Presentation Prepared By Listed Entity For Analyst Or Institutional Investor Meet
Yes
SCORES Registration ID
comr07665
Scrip Code
544578
Secretarial Compliance Report
Not Applicable
Separate Audited Financial Statements Of Each Subsidiary Of The Listed Entity
Yes
Shareholding Pattern
Yes
Statements Of Deviations Or Variations As Specified In Regulation32
Not Applicable
Symbol
RUBICON
The Listed Entity Has Approved Material Subsidiary Policy And The Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity Have Been Complied
Yes
Type Of Company
Equity
Type Of Submission
Original
Vacancies In Respect Key Managerial Personnel
Not Applicable
Vigil Mechanism
Yes
Whether As Per Sub Regulation2ba Of Regulation27Of SEBILODR There Has Been Cyber Security Incidents During The Quarter
No
Whether Part A Of Annexure I Of The SEBI Circular Dated31December2024Related To Compliance Report On Corporate Governance Is Applicable To The Entity
Yes
Whether Part F Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Loans Or Guarantees Or Comfort Letters Or Securities Etc Is Applicable To The Entity
No

Additional Disclosures

Entry D_MeetingBOD1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD3
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD4
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit10
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit11
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit3
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit4
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit5
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit6
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit7
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit8
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit9
Whether Requirement Of Quorum Met
Yes
Official NSE disclosure viewer

If the viewer does not load, use the NSE Viewer button above to open it in a new tab.

Board Composition — Entity Disclosures

The Composition Of Board Of Directors Is In Terms Of Sebi Regulations2015
Yes
Chairperson Related to MD / CEO
No
Regular Chairperson
Yes

Composition of Board of Directors

SrTitleDirectorPANDINCategory 1Category 2Category 3Date of BirthDisqualifiedStatusSpecial ResolutionInitial AppointmentRe-appointmentCessationTenure (months)Listed DirectorshipsIndependent DirectorshipsAudit / Stakeholder MembershipsAudit / Stakeholder Chair Posts
1MrsPratibha Sudhir Pilgoankar******00401516Executive DirectorNot ApplicableMD12-Jun-1954NoActiveNot Applicable01-Jun-20001000
2MrParag Suganchand Sancheti******07686819Executive DirectorNot ApplicableCEO16-Oct-1983NoActiveNot Applicable27-Jan-20171010
3MrVarun Talukdar******08312687Non-Executive - Non Independent DirectorNot Applicable18-May-1984NoActiveNot Applicable05-Sep-20231000
4MrShantanu Rastogi******06732021Non-Executive - Non Independent DirectorNot Applicable26-Mar-1979NoActiveNot Applicable03-Apr-20193020
5MrAnand Agarwal******06481297Non-Executive - Non Independent DirectorNot Applicable12-May-1976NoInactiveNot Applicable03-Jan-202503-Feb-20261000
6MrChangavalli Venkat******02391159Non-Executive - Independent DirectorChairperson25-Sep-1953NoActiveNot Applicable11-Jun-202411-Jun-202421.211110
7MrKumarapuram Gopalakrishnan Ananthakrishnan******00019325Non-Executive - Independent DirectorNot Applicable10-Feb-1957NoActiveNot Applicable11-Jun-202411-Jun-202421.213342
8MrMilind Anil Patil******02546815Non-Executive - Independent DirectorNot Applicable01-Nov-1963NoActiveNot Applicable11-Jul-202411-Jul-202420.212221
9MsPRADNYA NANDKUMAR SARAVADE******08472973Non-Executive - Independent DirectorNot Applicable18-Jun-1964NoActiveNot Applicable03-Feb-202603-Feb-202629-Jan-20261120

Committee Disclosures

Entry CompComit122
Date of Appointment
27-Dec-2014
Entry CompComit123
Date of Appointment
21-Feb-2017
Entry CompComit124
Date of Appointment
24-Jul-2024
Entry CompComit125
Date of Appointment
03-Feb-2026
Entry CompComit14
Date of Appointment
24-Jul-2024
Entry CompComit15
Date of Appointment
24-Jul-2024
Entry CompComit16
Date of Appointment
24-Jul-2024
Entry CompComit41
Date of Appointment
24-Jul-2024
Entry CompComit42
Date of Appointment
24-Jul-2024
Entry CompComit43
Date of Appointment
24-Jul-2024
Entry CompComit68
Date of Appointment
24-Jul-2024
Entry CompComit69
Date of Appointment
24-Jul-2024
Entry CompComit70
Date of Appointment
24-Jul-2024
Entry CompComit71
Date of Appointment
03-Feb-2026
Entry CompComit95
Date of Appointment
24-Jul-2024
Entry CompComit96
Date of Appointment
24-Jul-2024
Entry CompComit97
Date of Appointment
24-Jul-2024
Entry MainD
Composition And Role Of Risk Management Committee
Not Applicable
Composition Of Audit Committee
Yes
Composition Of Nomination And Remuneration Committee
Yes
Composition Of Stakeholder Relationship Committee
Yes
Composition Of Various Committees Of Board Of Directors
Yes
Disclosure Web Link Of Company At Which Composition Of Various Committees Of Board Of Directors Is Placed
https://www.rubicon.co.in/pdf/Rubicon%20Committee%20Constitution.pdf
Memberships In Committees
Yes
Prior Or Omnibus Approval Of Audit Committee For All Related Party Transactions
Yes
Risk Management Committee
Yes
Role Of Audit Committee And Information To Be Reviewed By The Audit Committee
Yes
Role Of Nomination And Remuneration Committee
Yes
Role Of Stakeholders Relationship Committee
Yes
The Committee Members Have Been Made Aware Of Their Powers Role And Responsibilities As Specified In Sebi Regulations2015
Yes
The Composition Of Audit Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Nomination And Remuneration Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Risk Management Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Stakeholders Relationship Committee Committee Is In Terms Of Sebi Regulations2015
Yes
Whether The Audit Committee Has A Regular Chairperson
Yes
Whether The Corporate Social Responsibility Committee Has A Regular Chairperson
Yes
Whether The Nomination And Remuneration Committee Has A Regular Chairperson
Yes
Whether The Risk Management Committee Has A Regular Chairperson
Yes
Whether The Stakeholders Relationship Committee Has A Regular Chairperson
Yes

Audit Committee

Additional Position
Chairperson
Director DIN
02546815
Member Name
Milind Anil Patil
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
02391159
Member Name
Changavalli Venkat
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
06732021
Member Name
Shantanu Rastogi
Position
Non-Executive - Non Independent Director

Audit Committee

Audit Committee

Audit Committee

Corporate Social Responsibility Committee

Additional Position
Chairperson
Director DIN
00401516
Member Name
Pratibha Sudhir Pilgoankar
Position
Executive Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
07686819
Member Name
Parag Suganchand Sancheti
Position
Executive Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
02391159
Member Name
Changavalli Venkat
Position
Non-Executive - Independent Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
08472973
Member Name
PRADNYA NANDKUMAR SARAVADE
Position
Non-Executive - Independent Director

Corporate Social Responsibility Committee

Corporate Social Responsibility Committee

Corporate Social Responsibility Committee

Nomination and remuneration committee

Additional Position
Chairperson
Director DIN
00019325
Member Name
Kumarapuram Gopalakrishnan Ananthakrishnan
Notes
Mr. Kumarapuram Gopalakrishnan Ananthakrishnan was re-designated from Member to Chairperson with effect from October 13, 2025.
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
06732021
Member Name
Shantanu Rastogi
Position
Non-Executive - Non Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
02391159
Member Name
Changavalli Venkat
Notes
Mr. Venkat Changavalli was re-designated from Chairperson to Member with effect from October 13, 2025.
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Nomination and remuneration committee

Nomination and remuneration committee

Risk Management Committee

Additional Position
Chairperson
Director DIN
07686819
Member Name
Parag Suganchand Sancheti
Position
Executive Director

Risk Management Committee

Additional Position
Member
Director DIN
02546815
Member Name
Milind Anil Patil
Position
Non-Executive - Independent Director

Risk Management Committee

Additional Position
Member
Director DIN
08312687
Member Name
Varun Talukdar
Position
Non-Executive - Non Independent Director

Risk Management Committee

Stakeholders Relationship Committee

Additional Position
Chairperson
Director DIN
00019325
Member Name
Kumarapuram Gopalakrishnan Ananthakrishnan
Position
Non-Executive - Independent Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
06732021
Member Name
Shantanu Rastogi
Position
Non-Executive - Non Independent Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
07686819
Member Name
Parag Sugnachand Sancheti
Position
Executive Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
08472973
Member Name
PRADNYA NANDKUMAR SARAVADE
Position
Non-Executive - Independent Director

Stakeholders Relationship Committee

Entry MainD
Gap Between The Meetings Of The Risk Management Committee
Not Applicable
Meeting Of Audit Committee
Yes
Meeting Of Board Of Directors
Yes
Meeting Of Independent Directors
Yes
Meeting Of Nomination And Remuneration Committee
Yes
Meeting Of Risk Management Committee
Not Applicable
Meeting Of Stakeholders Relationship Committee
Yes
Quorum Of Board Meeting
Yes
Quorum Of Nomination And Remuneration Committee Meeting
Yes
Quorum Of Risk Management Committeemeeting
Not Applicable
The Meetings Of The Board Of Directors And The Above Committees Have Been Conducted In The Manner As Specified In Sebi Regulations2015
Yes
Entry MeetingBOD1
Dates Of Meeting In The Previous Quarter
16-Dec-2025
Number Of Directors Present In Meeting Of Board Of Directors
8
Number Of Independent Directors Attending The Meeting
3
Total Number Of Directors As On Date Of The Meeting
8
Entry MeetingBOD2
Dates Of Meeting If Any In The Relevant Quarter
03-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
48
Number Of Directors Present In Meeting Of Board Of Directors
8
Number Of Independent Directors Attending The Meeting
3
Total Number Of Directors As On Date Of The Meeting
8
Entry MeetingBOD3
Dates Of Meeting If Any In The Relevant Quarter
12-Mar-2026
Maximum Gap Between Any Two Consecutive Meetings
36
Number Of Directors Present In Meeting Of Board Of Directors
6
Number Of Independent Directors Attending The Meeting
3
Total Number Of Directors As On Date Of The Meeting
8
Entry MeetingBOD4
Dates Of Meeting If Any In The Relevant Quarter
31-Mar-2026
Maximum Gap Between Any Two Consecutive Meetings
18
Number Of Directors Present In Meeting Of Board Of Directors
7
Number Of Independent Directors Attending The Meeting
3
Total Number Of Directors As On Date Of The Meeting
8
Entry MeetingComit1
Dates Of Meeting Of The Committee In The Previous Quarter
13-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit10
Dates Of Meeting Of The Committee In The Relevant Quarter
31-Mar-2026
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
1
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit11
Dates Of Meeting Of The Committee In The Relevant Quarter
30-Mar-2026
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
4
Entry MeetingComit2
Dates Of Meeting Of The Committee In The Relevant Quarter
03-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
81
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit3
Dates Of Meeting Of The Committee In The Relevant Quarter
30-Mar-2026
Maximum Gap Between Any Two Consecutive Meetings
54
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
2
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit4
Dates Of Meeting Of The Committee In The Previous Quarter
29-Oct-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit5
Dates Of Meeting Of The Committee In The Relevant Quarter
03-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
96
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit6
Dates Of Meeting Of The Committee In The Relevant Quarter
30-Mar-2026
Maximum Gap Between Any Two Consecutive Meetings
54
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
2
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit7
Dates Of Meeting Of The Committee In The Previous Quarter
13-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
1
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit8
Dates Of Meeting Of The Committee In The Relevant Quarter
18-Mar-2026
Maximum Gap Between Any Two Consecutive Meetings
124
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
4
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
4
Entry MeetingComit9
Dates Of Meeting Of The Committee In The Relevant Quarter
31-Mar-2026
Maximum Gap Between Any Two Consecutive Meetings
12
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
4
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
4
Entry MainD
Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances
Yes
Disclosure Web Link Of Company At Which Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances Is Placed
https://www.rubicon.co.in/investors#
Disclosure Web Link Of Company At Which Email Address For Grievance Redressal And Other Relevant Details Is Placed
http://rubicon.co.in/investors#
Email Address For Grievance Redressal And Other Relevant Details
Yes
No Of Investor Complaints Disposed Off During The Period
5
No Of Investor Complaints During The Period
0
No Of Investor Complaints Received During The Period
5
Whether Part B Of Annexure I Of The SEBI Circular Dated31December2024Related To Investor Grievance Redressal Report Is Applicable To The Entity
Yes
Entry MainI
No Of Investor Complaints
0
Entry PY_I
No Of Investor Complaints
0
Entry D_AcquisitionShares1
Percentage Of Shares Or Voting Rights Acquired During The Quarter
0.069
Entry I_AcquisitionShares_PY1
Percentage Of Aggregate Holding Of Shares Or Voting Rights
0
Entry I_AcquisitionShares1
Date Of Acquisition
27-Mar-2026
Name Of The Unlisted Company In Which Shares Or Voting Rights Have Been Acquired
Radiance MH Sunrise Eleven Private Limited
Percentage Of Aggregate Holding Of Shares Or Voting Rights
0.069
Entry MainD
Composition Of Board Of Directors Of Unlisted Material Subsidiary
Yes
Whether Part C Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Acquisition Of Shares Or Voting Rights In Unlisted Companies Is Applicable To The Entity
Yes
Entry I_OngoingTaxLitigationsOrDisputes1
Current Status
All further information requested during the quarter was provided. As on 31-03-2026 , the matter is pending adjudication before the Commissioner of Income-tax (Appeals) / NFAC .
Date of Initiation
26-Sep-2022
Opposing Party
Office of the assessment unit of Income Tax Department
Status (Previous Disclosure)
Status as on 31 December 2025: Submissions were filed and the matter is awaiting for disposal. No final adverse order has been passed as on 31-12-2025. Brief: Company received an assessment order dated September 26, 2022 (“AO Order”) from the office of the assessment unit of Income Tax Department under section143(3) read with section 144 B of the Income Tax Act, 1961 for an outstanding demand of ₹ 55.51 million imposed by assessing officer for the A.Y. 2020-21. The order was passed for inter alia disallowance u/s 14A and 37 of Income Tax Act, 1961 of the expense claimed on account of the difference between issue price and face value of shares issued pursuant to the ESOP Scheme of ₹ 79.41 million. The Company has filed an appeal dated October 21, 2022 with Hon’ble Commissioner of Income-Tax (Appeals). The matter is currently pending.
Entry I_OngoingTaxLitigationsOrDisputes2
Current Status
The Hon’ble CIT(A) / NFAC, vide order dated 28.03.2026 passed under section 250 of the Income-tax Act, 1961, allowed the appeal. The demand of Rs. 393.6 million arising on account of ICDS adjustment has been fully deleted, and the major issues has been adjudicated in favour of the Assessee. At present, only a minor issue remains, pertaining to interest on late payment of TDS amounting to Rs. 1,710.
Date of Initiation
26-Jul-2023
Opposing Party
Office of the assessment unit of Income Tax Department
Status (Previous Disclosure)
Last disclosure: Matter is awaiting adjudication; no final order received as on 31-12-2025. Brief: Company received an assessment order dated July 26, 2023 (“AO Order”) from the office of the assessment unit of Income Tax Department under section143(3) read with section 144 B of the Income Tax Act, 1961 for CASS scrutiny on the return of income filed. The total additional income tax demand raised as per AO Order is ₹ 407.36 million. Company filed an appeal dated April 19, 2024 with Hon’ble Commissioner of Income-Tax (Appeals), in relation to the demand for additional income tax raised. The matter is currently pending.
Entry I_OngoingTaxLitigationsOrDisputes3
Current Status
The Company will contesting the matter in appeal before the appropriate appellate authority against the draft assesssment order received during the quarter under Section 144C(1) of the Income-tax Act, 1961, with an addition of Rs. 206.8 million has been proposed on account of adjustment in the Arm’s Length Price (ALP) as suggested by the Transfer Pricing Office.
Date of Initiation
29-Dec-2023
Opposing Party
Intimation order u/s 143(1) of the Income Tax Act, 1961
Status (Previous Disclosure)
Last Disclosure: Matter pending with the Income-tax Department as on 31-12-2025. No final rectification / disposal as on 31-12-2025. Brief: Company received an intimation order u/s 143(1) of the Income Tax Act, 1961 dated December 12, 2023 for an outstanding amount payable of ₹ 81.42 million. On December 29, 2023, our Company paid ₹ 75.24 million out of the outstanding amount payable determined by the intimation order dated December 12, 2023. Further, our Company intimated by way of a letter dated March 28, 2024 to Assessing Offer of the Income Tax Department about the foreign tax benefit claim (“Claim”) for A.Y. 2021-2022 and 2022-2023 on inter-corporate loan extended to wholly owned subsidiary in USA and had filed the belated form 67 for A.Y. 2021-2022 and 2022-2023 and claimed credit for the interest income on the said loan in income tax return filed for A.Y. 2023-24. The Company is awaiting a reply and the matter is currently pending.
Entry I_OngoingTaxLitigationsOrDisputes4
Current Status
This matter was voluntarily dismissed by Edenbridge on 10-03-2026.
Date of Initiation
13-Mar-2025
Opposing Party
Edenbridge Pharmaceuticals LLC
Status (Previous Disclosure)
Last Disclosure: ngoing. The matter is currently pending. Brief: Plaintiff withdrew it's Motion for Preliminary Injunction on 26-09-2025. Brief: Edenbridge Pharmaceuticals LLC filed a complaint against the Company and Advagen Pharma Ltd (Material Subsidiary) before before the Court of Chancery for the State of Delaware, for: (i) breach of contract; (ii) misappropriation of trade secrets; and (iii) unjust enrichment. The Company and its Material Subsidiary has denied breach of the said confidentiality agreement.(Refer Prospectus for detailed proceedings)
Entry I_OngoingTaxLitigationsOrDisputes5
Current Status
Status as on March 31, 2026: Ongoing. The matter is currently pending.
Date of Initiation
23-May-2024
Opposing Party
Pfizer INC. and Pfizer Ireland Pharmaceuticals
Status (Previous Disclosure)
Last Disclosure: Ongoing. The matter is currently pending. Brief:Pfizer INC. and Pfizer Ireland Pharmaceuticals filed a complaint against the Company before United States District Court for the District of Delaware, for patent infringement under patent laws of the United States of America arising from Company’s submission for abbreviated new drug application no. 219440 to the US FDA. (Refer Prospectus for detailed proceedings)
Entry I_OngoingTaxLitigationsOrDisputes6
Current Status
Status as on March 31, 2026: Closed. This matter was settled and case closed during the reporting quarter.
Date of Initiation
12-Jul-2024
Opposing Party
Pierre Fabre Medicament SAS; Université De Bordeaux; Centre Hospitalier Universitaire De Bordeaux; and Pierre Fabre Pharmaceuticals, Inc., (“Plaintiffs”)
Status (Previous Disclosure)
Last Disclosure: Ongoing. The matter is currently pending. Brief:Plaintiffs filed a complaint against the Company before United States District Court for the District of Delware for patent infringement under patent laws of the United States of America arising from Plaintiff’s submission for abbreviated new drug application (ANDA) no. 219574 to the US FDA (Refer Prospectus for detailed proceedings)
Entry I_OngoingTaxLitigationsOrDisputes7
Current Status
Status as on March 31, 2026: Ongoing. The matter is currently pending.
Date of Initiation
08-Aug-2023
Opposing Party
Metacel Pharmaceuticals LLC (Counterclaim filed by Rubicon Research Limited
Status (Previous Disclosure)
Last Disclosure:Rubicon Counterclaim: Ongoing. The matter is currently in the discovery phase. The Metacel Patent Infringement Action - Metacel Pharmaceuticals LLC initiated a Complaint against Rubicon Research [Private] Limited on 29 October 2021. Rubicon won its Summary Judgment Motion, with a Final Judgment entered on 31 August 2023, the Court finding that “Rubicon’s ANDA Product that is the subject of ANDA No. 214445 (the “Rubicon ANDA”) does not infringe any claim of the ’502 patent.” Rubicon successfully defended its Judgment before the U.S. Court of Appeals for the Federal Circuit and returned the action to U.S. District Court (see e.g. Dkt. Nos. 164 and 170.) The Rubicon Antitrust Counterclaim - Defendant, Rubicon Research [Private] Limited’s First Amended Answer, Affirmative Defenses and Counterclaim was filed on 8 August 2023, thereby initiating suit against Counterclaim Defendant, Metacel. The Counterclaim action would be stayed, by virtue of Metacel’s Appeal of the Trial Court’s Final Judgment of Non-Infringement, to the U.S. Court of Appeals for the Federal Circuit. Following entry of the Fed. Cir. Opinion affirming the Trial Court’s Decision on 23 April 2025, Rubicon sought and received an Order lifting the case stay (Dkt. No. 168) and has continued to pursue its antitrust counterclaim against Metacel through 31 December 2025.
Entry I_OngoingTaxLitigationsOrDisputes8
Current Status
AdvaGen Pharma Ltd, USA, a material step down subsidiary company, received a demand notice under section 156 of the Income-Tax Act, 1961 from the office of Deputy Commissioner of Income Tax, Mumbai. The notice specifies the total demand payable including tax and interest of INR 4,18,84,613/- for assessment year 2021-22. This arises from the denial of a DTAA exemption on income of INR 10,03,57,800, following the tax authority’s conclusion that the 'Make Available' clause under the India-US DTAA was applicable. Assessment year 2021-22. On 19/01/26, an Appeal has been filed before the Income Tax Appellate Tribunal (ITAT), against the assessment order passed under Section 143(3) read with Section 144C(13) of the Income-tax Act, 1961. As on 31-03-2026, the matter is currently pending.
Date of Initiation
05-Jan-2026
Opposing Party
Office of Deputy Commissioner of Income Tax, Mumbai
Status (Previous Disclosure)
Not Applicable
Entry MainD
Whether Part E Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Updates To Ongoing Tax Litigations Or Disputes Is Applicable To The Entity
Yes
Entry I_ImpositionOfFineOrPenalty1
Authority
Reserve Bank of India (Foreign Exchange Department)
Date Of Receipt Of Direction Or Order Including Any Ad Interim Or Interim Orders Or Any Other Communication From The Authority
06-Jan-2026
Financial / Operational Impact
289000
Nature And Details Of The Action Taken Or Order Passed
Compounding Order passed under Section 15 of FEMA, 1999 for regularization of contravention. The matter was disposed upon payment of compounding amount.
Violation Details
Delay in filing Form ESOP beyond prescribed timeline (30 days) under FEMA 20(R) Regulations, 2017 relating to issuance of ESOPs to a non-resident employee
Entry I_ImpositionOfFineOrPenalty2
Authority
Indian Customs (Air Cargo Complex, Sahar, Mumbai)
Date Of Receipt Of Direction Or Order Including Any Ad Interim Or Interim Orders Or Any Other Communication From The Authority
02-Jan-2026
Financial / Operational Impact
5000
Nature And Details Of The Action Taken Or Order Passed
Final assessment of Bill of Entry with levy of fine
Violation Details
Procedural / assessment-related matter (no offence or penalty)
Entry I_ImpositionOfFineOrPenalty3
Authority
Indian Customs (Air Cargo Complex, Sahar, Mumbai)
Date Of Receipt Of Direction Or Order Including Any Ad Interim Or Interim Orders Or Any Other Communication From The Authority
03-Jan-2026
Financial / Operational Impact
6000
Nature And Details Of The Action Taken Or Order Passed
Final assessment of Bill of Entry with levy of fine
Violation Details
Procedural / assessment-related matter (no offence or penalty)
Entry I_ImpositionOfFineOrPenalty4
Authority
Indian Customs (Air Cargo Complex, Sahar, Mumbai)
Date Of Receipt Of Direction Or Order Including Any Ad Interim Or Interim Orders Or Any Other Communication From The Authority
18-Feb-2026
Financial / Operational Impact
10000
Nature And Details Of The Action Taken Or Order Passed
Final assessment of Bill of Entry with levy of fine
Violation Details
Procedural / assessment-related matter (no offence or penalty)
Entry MainD
Whether Part D Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Imposition Of Fine Or Penalty Is Applicable To The Entity
Yes